On our screens:Cheap stocks by free cash flow yield
What is the market doing?
What the tape says about VTRS
Viatris is +63% over the past year while the S&P 500 is +20%: 42 points ahead of the market.
+63%
1-year return · S&P 500 +20%
- vs 200-day average
- +17%
vs 200-day average · a clear uptrend
- RSI (14)
- 57
RSI (14) · neutral
- Below its 52-week high
- 7.0%
Below its 52-week high
Details›
- Last close2026-09-08
- $16.62
- 1 monthS&P 500 −0.30%
- +2.2%
- 1 yearS&P 500 +20%
- +63%
- 5 yearsS&P 500 +85%
- +36%
- vs 50-day average$16.56
- +0.36%
- 52-week high
- $17.87
- 52-week low
- $9.23
- Annualised volatility
- 34%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$284K
| Year | Return |
|---|---|
| 2026 (year to date) | +36% |
| 2025 | +5.1% |
| 2024 | +20% |
| 2023 | +2.1% |
| 2022 | −14% |
| 2021 | −26% |
| 2020 | −6.8% |
| 2019 | −27% |
| 2018 | −35% |
| 2017 | +11% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +3.2% |
| Feb | 10 | 3 of 10 | −7.1% |
| Mar | 10 | 2 of 10 | −4.8% |
| Apr | 10 | 2 of 10 | −1.1% |
| May | 10 | 6 of 10 | +1.1% |
| Jun | 10 | 4 of 10 | −1.1% |
| Jul | 11 | 8 of 11 | +3.8% |
| Aug | 11 | 6 of 11 | −0.52% |
| Sep | 11 | 2 of 11 | −5.5% |
| Oct | 10 | 3 of 10 | +0.21% |
| Nov | 10 | 8 of 10 | +5.1% |
| Dec | 10 | 8 of 10 | +6.0% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
The closest names by size in the same industry